Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: Biological and clinical implications

Human Pathology

Volumn 30, Issue 9, 1999, Pages 1013-1018

  El Naggar, Adel K ^a   Lai, Syeling ^a   Clayman, Gary L ^a   Zhou, Jain Hua ^a   Tucker, Susan A ^a   Myers, Jeffrey ^a   Luna, Mario A ^a   Benedict, William F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell cycle; Head and neck squamous carcinoma; Immunohistochemistry; Tumor suppressor gene; Western blotting

Indexed keywords

CYCLIN D1; PROTEIN P16;

ADULT; AGED; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0032887604     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90217-4     Document Type: Article

References (38)

1. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323-330, 1995.
2. Hall M, Peters G: Genetic alterations of cyclins, cyclin-dependent kinases and cdk inhibitors in human cancer. Adv Cancer Res 68:67-108, 1996
3. Sherr CJ: Cancer cell cycles. Science 274:1672-1677, 1996
4. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, et al: Hypophosphorylation of the retinoblastoma protein (pRb) by Cyclin D: Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci 94:10699-10704, 1997
5. Lukas J, Parry D, Aagaard L, et al: Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature (Lond) 375:503-506, 1995
6. Otterson GA, Kratzke RA, Coxon A, et al: Absence of p16 INK4 protein in restricted to the subset of lung cancer lines that retains wild type RB. Oncogene 9:3375-3378, 1994
7. Sakaguchi M, Fujii Y, Hirabayashi H, et al: Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study. Int J Cancer 65:442-445, 1996
8. Shapiro GI, Edwards CD, Kobzik L, et al: Reciprocal Rb inactivation and p16 INK4 expression in primary lung cancers and cell lines. Cancer Res 55:505-509, 1995
9. Ueki K, Ono Y, Henson JW, et al: CDKN2/p16 or Rb alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150-153, 1996
10. Yeager T, Stadler W, Belair C, et al: Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 55:493-497, 1995
11. INK4 expression in resected non-small-cell lung tumors. Cancer Res 56:3414-3420, 1996
12. ink4//mts1 tumor suppressor gene product. EMBO J 14:503-511, 1995
13. Muller H, Lukas J, Schneider A, et al: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949, 1994
14. Fang X, Jin Z, Xu HJ, et al: Expression of p16 induces transcriptional downregulation of the Rb gene. Oncogene 16:1-8, 1998
15. Tanaka H, Fuji Y, Hirabayashi H, et al: Disruption of the Rb pathway and cell-proliferative activity in non-small cell lung cancers. IntJ Cancer (Pred Oncol) 79:111-115, 1998
16. Dublin EA, Patel NK, Gillet CE, et al: Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and pathological parameter. Int J Cancer (Pred Oncol) 79:71-75, 1998
17. March KL, Varley JM: Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohisto-chemistry. Br J Cancer 77:1460-1468, 1998
18. Michalides R, Hageman PH, van Tinteren H, et al: A clinicopathologic study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73:728-734, 1996
19. van Diest PJ, Michalides RJ, Jannink I, et al: Cyclin D1 expression in invasive breast cancer: Correlations and prognostic value. Am J Pathol 150:705-711, 1997
20. Varley JM, Armour J, Swallow JE, et al: The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 4:725-729, 1989
21. Stauss M, Gusterson B, Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55:949-956, 1995
22. Maelandsmo GM, Florenes VA, Hovig E, et al: Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br J Cancer 73:909-916, 1996
23. Nielsen NH, Emdin SO, Cajander J, et al: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14:295-304, 1997
24. Reed AL, Califano J, Cairns P, et al: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation of head and neck squamous cell carcinoma. Cancer Res 56:3630-3633, 1996
25. El-Naggar AK, Lai S, Clayman G, et al: Methylation: A dominant mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 151:1767-1774, 1997
26. Olshan AF, Weissler MC, Pei H, et al: Alterations of the p16 gene in head and neck cancer: Frequency and association with p53, PRAD-1 and HPV. Oncogene 14:811-818, 1997
27. ink4 in archival human solid tumors: Correlation with retinoblastoma protein expression. Cancer Res 54:6006-6011, 1995
28. Xu HJ, Cagle PT, Hu SX, et al: Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: Potential synergistic effects on prognosis. Clin Cancer Res 2:1169-1176, 1996
29. Xu HJ, Hu SX, Hashimoto T, et al: The retinoblastoma susceptibility gene product: A characteristic pattern in normal cells and abnormal expression in malignant. Oncogene 4:807-812, 1989
30. Benedict WF, Lerner SP, Zhou J, et al: Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/ CDKN2) status in bladder cancer. Oncogene 18:1197-1203, 1999
31. Xu HJ, Cairns P, Hu SX, et al: Loss of Rb protein expression in primary bladder cancer correlates with loss of heterozygosity at the Rb locus and tumor progression. Int J Cancer 53:781-784, 1993
32. INK4a inactivation in non-small cell lung cancer cell lines. Cancer Res 55:6200-6209, 1995
33. Roncalli M, Bosari S, Marchetti A, et al: Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. Lab Invest 78:1049-1057, 1998
34. Gillett C, Smith P, Gregory W, et al: Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69:92-99, 1996
35. WAF1 immunohistochemical expression. In J Cancer 74:171-174, 1997
36. Schuuring E, Verhoeven E, Tinteren H van, et al: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 52:5229-5234, 1991
37. Lammie G, Fantl V, Smith R, et al: D112287, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and linked to bc1-1. Oncogene 6:439-444, 1991
38. Michalides R, van Veelee N, Hart A, et al: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975-978, 1995